openPR Logo
Press release

Prominent Lipid Regulators Market Trend for 2025: Advancements In Oral Lipid-Lowering Drugs For Managing High Cholesterol In Cardiac Patients

03-20-2025 07:12 AM CET | Health & Medicine

Press release from: The Business Research Company

Lipid Regulators

Lipid Regulators

Which drivers are expected to have the greatest impact on the over the lipid regulators market's growth?
The growing prevalence of cardiovascular diseases is expected to drive the growth of the angina pectoris drug market. Cardiovascular diseases, including coronary artery disease and heart failure, are on the rise due to aging populations and unhealthy lifestyles. Drugs for angina pectoris, a symptom of heart disease, are becoming increasingly important in managing cardiovascular health. According to the British Heart Foundation, 7.6 million people in the UK are affected by heart and circulatory diseases, which are responsible for a significant portion of the country's deaths. This growing prevalence is contributing to the demand for angina pectoris drugs.

Get Your Lipid Regulators Market Report Here:
https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

What is the future CAGR of the lipid regulators market, and how will it impact industry expansion?
The lipid regulators market will grow from $7.29 billion in 2024 to $7.82 billion in 2025 at a CAGR of 7.2%, supported by increased healthcare spending, aging populations, and heightened awareness of cholesterol management.

The lipid regulators market is expected to grow to $10.2 billion by 2029 at a CAGR of 6.9%. Contributing factors include rising metabolic syndrome cases, an aging population, and increasing obesity rates. Trends include advancements in drug formulation, digital health integration, over-the-counter medication availability, and value-based pricing models.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15848&type=smp

What are the most significant trends transforming the lipid regulators market today?
Companies in the lipid regulator market are advancing oral lipid-lowering drugs to manage high LDL cholesterol in heart disease patients. These oral medications are especially beneficial for those with genetic cholesterol disorders or existing heart conditions. For example, in May 2022, Sun Pharmaceutical Industries launched Bempedoic Acid Brillo in India. This oral drug targets high LDL cholesterol by inhibiting an enzyme involved in cholesterol production, making it more convenient than other treatments.

Which key market segments comprise the lipid regulators market and drive its revenue growth?
The lipid regulators market covered in this report is segmented -

1) By Type: Lipid Regulators, Narcotic Analgesics, Angiotensin Converting Enzyme (ACE) Inhibitors, Respiratory Agents, Diuretics, Calcium Antagonists, Hormonal Contraceptives, Other Types
2) By Indication: Hypercholesterolemia, Hypertriglyceridemia, Coronary Artery Disease, Other Indications
3) By Administration: Oral, Injectable
4) By Application: Pharmaceuticals, Vaccines And Drugs, Scientific Research, Nutrition And Supplements, Food And Beverages, Other Applications

Subsegments:
1) By Lipid Regulators: Statins, Fibrates, Niacin, Omega-3 Fatty Acids
2) By Narcotic Analgesics: Opioid Analgesics, Combination Analgesics (Opioid And Non-opioid), Antagonists For Pain Relief
3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Captopril, Enalapril, Lisinopril, Ramipril
4) By Respiratory Agents: Bronchodilators, Corticosteroids, Antihistamines
5) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics
6) By Calcium Antagonists: Dihydropyridines, Non-Dihydropyridines
7) By Hormonal Contraceptives: Oral Contraceptives, Injectable Contraceptives, Implantable Contraceptives
8) By Other Types: Beta Blockers, Anticoagulants, Antiplatelets

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15848

What regions are at the forefront of lipid regulators market expansion?
North America was the largest region in the lipid regulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid regulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the lipid regulators market?
Major companies operating in the lipid regulators market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Limited, Dr. Reddy's Laboratories Ltd., Biocon Ltd., Alnylam Pharmaceuticals Inc., Amarin Corporation plc, Arrowhead Pharmaceuticals Inc., Kowa Pharmaceuticals America Inc., Esperion Therapeutics Inc., Bentley Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Andrx Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15848&type=smp

What Is Covered In The Lipid Regulators Global Market Report?

•Market Size Forecast: Examine the lipid regulators market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the lipid regulators market for a structured understanding.
•Key Players Overview: Analyze major players in the lipid regulators market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the lipid regulators market.
•Segment Contributions: Evaluate how different segments drive overall growth in the lipid regulators market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the lipid regulators market.
•Industry Challenges: Identify potential risks and obstacles affecting the lipid regulators market.
•Competitive Landscape: Review strategic developments in the lipid regulators market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prominent Lipid Regulators Market Trend for 2025: Advancements In Oral Lipid-Lowering Drugs For Managing High Cholesterol In Cardiac Patients here

News-ID: 3925926 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the